How much does a bottle of enzalutamide cost? What are the purchasing channels?
Enzalutamide is a drug used to treat prostate cancer, specifically castration-resistant prostate cancer. In 2024, enzalutamide will be officially launched on the Chinese market and has been included in the medical insurance system. With the introduction of the medical insurance reimbursement policy, the financial burden of patients purchasing the drug domestically has been significantly reduced. Enzalutamide is available on the market in two options: original drug and domestic generic drug. The price varies depending on the source of the drug and medical insurance reimbursement.
In China, the original drug specification of enzalutamide is 40mg*112 tablets. After reimbursement by medical insurance, the price patients need to pay is approximately 5,000 yuan. However, the specific costs may vary depending on the medical insurance reimbursement ratio in different regions, and patients in some regions may pay less out-of-pocket. Medical insurance reimbursement makes original drugs a more feasible treatment option. Although the price is higher, the price/performance ratio is better than some imported drugs or generic drugs.

In addition to original drugs, domestic generic drugs have also been launched in the domestic market. Domestic generic versions of enzalutamide are similar in efficacy to the original drug, but are usually less expensive. Compared with original drugs, domestic generic drugs are more cost-effective. For some patients with more limited financial conditions, domestic generic drugs may be a more attractive option. In India, the price of generic drugs of the same specifications is about 2,800 yuan, which is more affordable and suitable for patients who are not covered by domestic medical insurance.
In addition to domestic purchases, patients can also choose to purchase overseas. For example, there is also a generic version of enzalutamide in Laos. The price of 40mg*60 capsules is less than 4,000 yuan. Compared with the domestic market price, the price of the Lao version of the drug is even lower. For patients who require long-term treatment, choosing the appropriate purchasing channel can effectively reduce the cost of treatment. Whether choosing domestic generic drugs or imported generic drugs, patients should make a choice based on their own economic situation and treatment needs, and purchase drugs through formal channels to ensure quality and efficacy.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)